(May 20, 2016, 10:45 AM EDT) -- SILVER SPRING, Md. — The Food and Drug Administration on May 18 said it is investigating interim safety results from an ongoing clinical trial that found an increase in leg and foot amputation in patients treated with the diabetes drug Invokana....